BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20873464)

  • 1. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new biomarkers of heart failure.
    Emdin M; Vittorini S; Passino C; Clerico A
    Eur J Heart Fail; 2009 Apr; 11(4):331-5. PubMed ID: 19329823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
    Perna ER; Címbaro Canella JP; Macin SM
    Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac biomarkers and pulmonary embolism: prognostic stratification].
    Blaudszun G; Vuilleumier N; Righini M; Louis-Simonet M
    Rev Med Suisse; 2009 Oct; 5(221):2022-4, 2026-7. PubMed ID: 19911687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
    Nagarajan V; Tang WH
    Congest Heart Fail; 2011; 17(4):169-74. PubMed ID: 21790966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin levels in heart failure.
    Potluri S; Ventura HO; Mulumudi M; Mehra MR
    Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in acute decompensated heart failure: the role of cardiac troponin.
    Mueller C
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):680-1. PubMed ID: 18779830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of biomarkers in cardiac failure].
    Paredes C A; Vega J; de León A; Kanacri A; Castro P; Baeza R
    Rev Med Chil; 2013 Dec; 141(12):1560-9. PubMed ID: 24728434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.
    Kociol RD; Pang PS; Gheorghiade M; Fonarow GC; O'Connor CM; Felker GM
    J Am Coll Cardiol; 2010 Sep; 56(14):1071-8. PubMed ID: 20863950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of myocyte injury in heart failure.
    Latini R; Masson S
    Heart Fail Clin; 2009 Oct; 5(4):529-36. PubMed ID: 19631177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac biomarkers in perioperative risk stratification].
    Fellahi JL; Piriou V; Longrois D
    Ann Fr Anesth Reanim; 2011 Feb; 30(2):126-40. PubMed ID: 21282034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis.
    Lega JC; Lacasse Y; Lakhal L; Provencher S
    Thorax; 2009 Oct; 64(10):869-75. PubMed ID: 19525265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers after heart transplantation: nongenomic.
    Dengler TJ; Gleissner CA; Klingenberg R; Sack FU; Schnabel PA; Katus HA
    Heart Fail Clin; 2007 Jan; 3(1):69-81. PubMed ID: 17545010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy.
    Ricciardi G; Pieragnoli P; Colella A; Giaccardi M; Padeletti L; Abbate R; Gensini GF; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):743-52. PubMed ID: 17167386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.